BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol 2014; 20(10): 2595-2605 [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Mastrorilli G, Fiorentino F, Tucci C, Lombardi G, Aghemo A, Colombo GL. Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures. CEOR 2022;Volume 14:205-20. [DOI: 10.2147/ceor.s354470] [Reference Citation Analysis]
2 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Lin YY, Hu CT, Sun DS, Lien TS, Chang HH. Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice. Sci Rep 2019;9:17497. [PMID: 31767905 DOI: 10.1038/s41598-019-53977-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
4 Chow JH, Lee K, Abuelkasem E, Udekwu OR, Tanaka KA. Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics. Semin Cardiothorac Vasc Anesth 2018;22:164-73. [DOI: 10.1177/1089253217739689] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
5 Alavian SM, Imanieh MH, Imanieh MH. Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections. Hepat Mon. 2016;16:e34790. [PMID: 27330536 DOI: 10.5812/hepatmon.34790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Yoshida M, Tateishi R, Hiroi S, Hongo Y, Fujiwara M, Kitanishi Y, Iwasaki K, Takeshima T, Igarashi A. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease. Adv Ther 2022;39:379-90. [PMID: 34748184 DOI: 10.1007/s12325-021-01965-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sepehrinezhad A, Dehghanian A, Rafati A, Ketabchi F. Impact of liver damage on blood-borne variables and pulmonary hemodynamic responses to hypoxia and hyperoxia in anesthetized rats. BMC Cardiovasc Disord 2020;20:13. [PMID: 31931715 DOI: 10.1186/s12872-019-01297-z] [Reference Citation Analysis]
8 Rauber P, Lammert F, Grotemeyer K, Appenrodt B. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study. PLoS One 2018;13:e0192271. [PMID: 29438423 DOI: 10.1371/journal.pone.0192271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
9 Sigal SH, Sherman Z, Jesudian A. Clinical Implications of Thrombocytopenia for the Cirrhotic Patient. Hepat Med. 2020;12:49-60. [PMID: 32341665 DOI: 10.2147/hmer.s244596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Larkin CM, Santos-Martinez MJ, Ryan T, Radomski MW. Sepsis-associated thrombocytopenia. Thromb Res. 2016;141:11-16. [PMID: 26953822 DOI: 10.1016/j.thromres.2016.02.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
11 Mohamed SE, Yassin MA. Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report. Case Rep Oncol 2020;13:863-6. [PMID: 32884532 DOI: 10.1159/000507987] [Reference Citation Analysis]
12 Klompas AM, Boswell MR, Plack DL, Smith MM. Thrombocytopenia: Perioperative Considerations for Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00104-X. [PMID: 33707107 DOI: 10.1053/j.jvca.2021.02.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol 2016;27:1665-74. [PMID: 27595469 DOI: 10.1016/j.jvir.2016.05.039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
14 Abdel Moneim A, Suleiman HA, Mahmoud B, Mabrouk D, Zaky MY, Mahmoud B. Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4. Clin Exp Med 2020;20:231-40. [PMID: 32076917 DOI: 10.1007/s10238-019-00605-3] [Reference Citation Analysis]
15 Hegazy S, Elsabaawy M, Eltabakh M, Hammad R, Bedair H. CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis. Clin Exp Hepatol 2021;7:231-40. [PMID: 34295992 DOI: 10.5114/ceh.2021.107566] [Reference Citation Analysis]
16 Zhang XH, He Y, Feng R, Xu LP, Jiang Q, Jiang H, Lu J, Fu HX, Liu H, Wang JW, Wang QM, Feng FE, Zhu XL, Xu LL, Xie YD, Ma H, Wang H, Liu KY, Huang XJ. Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study. Platelets 2016;27:223-9. [PMID: 26338255 DOI: 10.3109/09537104.2015.1077946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M. Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures. Clin Gastroenterol Hepatol. 2019;17:1192-1200. [PMID: 30502505 DOI: 10.1016/j.cgh.2018.11.047] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
18 Ali I, Graham C, Dempsey-hibbert NC. Immature platelet fraction as a useful marker in the etiological determination of thrombocytopenia. Experimental Hematology 2019;78:56-61. [DOI: 10.1016/j.exphem.2019.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Uchinaka EI, Amisaki M, Yagyu T, Morimoto M, Watanabe J, Tokuyasu N, Sakamoto T, Honjo S, Saito H, Fujiwara Y. Prognostic Significance of Pre-surgical Combined Platelet Count and Neutrophil-Lymphocyte Ratio for Patients With Hepatocellular Carcinoma. In Vivo. 2019;33:2241-2248. [PMID: 31662563 DOI: 10.21873/invivo.11729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Uojima H, Arase Y, Itokawa N, Atsukawa M, Satoh T, Miyazaki K, Hidaka H, Sung JH, Kako M, Tsuruya K, Kagawa T, Iwakiri K, Horie R, Koizumi W. Relationship between response to lusutrombopag and splenic volume. World J Gastroenterol 2018; 24(46): 5271-5279 [PMID: 30581275 DOI: 10.3748/wjg.v24.i46.5271] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
21 Abd-Elsalam S, Habba E, Elkhalawany W, Tawfeek S, Elbatea H, El-Kalla F, Soliman H, Soliman S, Yousef M, Kobtan A, El Nawasany S, Awny S, Amer I, Mansour L, Rizk F. Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis. Medicine (Baltimore) 2016;95:e3853. [PMID: 27281094 DOI: 10.1097/MD.0000000000003853] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
22 Bucsics T, Lampichler K, Vierziger C, Schoder M, Wolf F, Bauer D, Simbrunner B, Hartl L, Jachs M, Scheiner B, Trauner M, Gruenberger T, Karnel F, Mandorfer M, Reiberger T. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis. Dig Dis Sci 2022. [PMID: 35301618 DOI: 10.1007/s10620-022-07443-6] [Reference Citation Analysis]
23 Medina JB, Andrade NS, de Paula Eduardo F, Bezinelli L, Franco JB, Gallottini M, Braz-Silva PH, Ortega KL. Bleeding during and after dental extractions in patients with liver cirrhosis. Int J Oral Maxillofac Surg 2018;47:1543-9. [PMID: 29705406 DOI: 10.1016/j.ijom.2018.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
24 Temel T, Cansu DU, Temel HE, Ozakyol AH. Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis. Hepat Mon 2014;14:e18556. [PMID: 24976834 DOI: 10.5812/hepatmon.18556] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
25 Sasaki R, Shiino C, Imawari M, Bentley R, Cai B, Yoshida M, Afdhal N. Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance. Hepatol Res 2019;49:1169-81. [PMID: 31228221 DOI: 10.1111/hepr.13392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Shukla J, Kalra N, Mittal BR, Duseja A, Kumar R, Singh H, Chaluvashetty SB, Parmar M, Krishnan S, Kumar G, Vatsa R, Chhabra A, Bansal K, Rathore Y, Pandey S. Freeze-dried microspheres for selective intra-arterial radionuclide therapy: an affordable solution. Nucl Med Commun 2020;41:817-23. [PMID: 32516242 DOI: 10.1097/MNM.0000000000001225] [Reference Citation Analysis]
27 Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment. World J Gastroenterol 2016; 22(4): 1541-1550 [PMID: 26819521 DOI: 10.3748/wjg.v22.i4.1541] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
28 Nakayama H, Takayama T. Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World J Hepatol 2015; 7(20): 2292-2302 [PMID: 26380653 DOI: 10.4254/wjh.v7.i20.2292] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Hassouna MM, Mostafa MS, Mohammed AM, Abdelwahed AS, Abd Elrhman HE, Ismail S, Abdallah HM. Heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) as a predictor of esophageal varices development in cirrhotic patients. Meta Gene 2022. [DOI: 10.1016/j.mgene.2022.101013] [Reference Citation Analysis]
30 Wang B, Chen F, Zhou Q, Zhou Y, Meng D, Geng P, Hua A, Ji W, Wang C, Wang S, Hu L. Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS. Int J Anal Chem 2020;2020:7290470. [PMID: 32550846 DOI: 10.1155/2020/7290470] [Reference Citation Analysis]
31 Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. Gastroenterology. 2018;155:705-718. [PMID: 29778606 DOI: 10.1053/j.gastro.2018.05.025] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 19.8] [Reference Citation Analysis]
32 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
33 Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50. [PMID: 27186144 DOI: 10.2147/hmer.s74612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
34 Laouénan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Marcellin P, Mentré F. A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. CPT Pharmacometrics Syst Pharmacol 2015;4:e00008. [PMID: 26225222 DOI: 10.1002/psp4.8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Oktaviono YH, Meuthia F. Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention. FMI 2021;55:68. [DOI: 10.20473/fmi.v55i1.24434] [Reference Citation Analysis]
36 Barnett CL, Mladsi D, Vredenburg M, Aggarwal K. Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures. Journal of Medical Economics 2018;21:827-34. [DOI: 10.1080/13696998.2018.1490301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
37 Chen XL, Yao X, Yang GD, Qin JP. Applications of vascular interventions in hypersplenism in liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2022; 30(3): 140-146 [DOI: 10.11569/wcjd.v30.i3.140] [Reference Citation Analysis]
38 Giustozzi M, Ehrlinder H, Bongiovanni D, Borovac JA, Guerreiro RA, Gąsecka A, Papakonstantinou PE, Parker WAE. Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment. Blood Rev 2021;:100864. [PMID: 34217531 DOI: 10.1016/j.blre.2021.100864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Saab S, Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci. 2019;64:2757-2768. [PMID: 31011942 DOI: 10.1007/s10620-019-05615-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
40 Miki N, Inoue S, Shibahara H, Kurazono K, Perard R, Tateishi R. A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan. JGH Open 2021;5:879-87. [PMID: 34386595 DOI: 10.1002/jgh3.12597] [Reference Citation Analysis]
41 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]
42 Saleem N, Miller LS, Dadabhai AS, Cartwright EJ. Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population. Medicine (Baltimore) 2021;100:e26200. [PMID: 34115003 DOI: 10.1097/MD.0000000000026200] [Reference Citation Analysis]
43 Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. Transfusion strategies in patients with cirrhosis. Eur J Haematol 2020;104:15-25. [PMID: 31661175 DOI: 10.1111/ejh.13342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
44 Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, Taki K, Nakagawa S, Okabe H, Hayashi H, Imai K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Beppu T, Baba H. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res 2017;47:991-9. [PMID: 28000365 DOI: 10.1111/hepr.12835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
45 Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K. A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation. J Gastroenterol. 2018; Epub ahead of print. [PMID: 30105510 DOI: 10.1007/s00535-018-1499-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
46 Sharma V. Use of eltrombopag in thrombocytopenia of liver disease. World J Pharmacol 2014; 3(4): 186-192 [DOI: 10.5497/wjp.v3.i4.186] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Fan X, Chen L, Yang J, Feng P. Entecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient: A Case Report and Literature Review. Medicine (Baltimore). 2016;95:e3103. [PMID: 27015182 DOI: 10.1097/md.0000000000003103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lucchini E, Fanin R, Cooper N, Zaja F. Management of immune thrombocytopenia in elderly patients. European Journal of Internal Medicine 2018;58:70-6. [DOI: 10.1016/j.ejim.2018.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Nishida Y, Kawaoka T, Imamura M, Namba M, Fujii Y, Uchikawa S, Ohya K, Daijo K, Teraoka Y, Morio K, Fujino H, Nakahara T, Yamauchi M, Hiramatsu A, Tsuge M, Aikata H, Takahashi S, Hayes CN, Fukuhara T, Tsuji K, Arataki K, Nagaoki Y, Aisaka Y, Kamada K, Kodama H, Chayama K. Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures. Intern Med 2021;60:829-37. [PMID: 33087674 DOI: 10.2169/internalmedicine.5930-20] [Reference Citation Analysis]
50 Soliman M, Hartmann M. Impedance Aggregometry Reveals Increased Platelet Aggregation during Liver Transplantation. J Clin Med 2019;8:E1803. [PMID: 31717891 DOI: 10.3390/jcm8111803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Ishikawa T, Okoshi M, Tomiyoshi K, Kojima Y, Horigome R, Imai M, Nozawa Y, Iwanaga A, Sano T, Honma T, Yoshida T. Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia. Hepatol Res. 2019;49:590-593. [PMID: 30602063 DOI: 10.1111/hepr.13305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
52 Adar T, Ilan Y, Elstein D, Zimran A. Liver involvement in Gaucher disease – Review and clinical approach. Blood Cells, Molecules, and Diseases 2018;68:66-73. [DOI: 10.1016/j.bcmd.2016.10.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
53 Lee SB, Kim HG, Kim HS, Lee JS, Im HJ, Kim WY, Son CG. Ethyl Acetate Fraction of Amomum xanthioides Exerts Antihepatofibrotic Actions via the Regulation of Fibrogenic Cytokines in a Dimethylnitrosamine-Induced Rat Model. Evid Based Complement Alternat Med 2016;2016:6014380. [PMID: 27594891 DOI: 10.1155/2016/6014380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
54 Huang SC, Li L, Rehman MU, Gao JD, Zhang LH, Tong XL, Waqas M, Li JK. Tibial growth plate vascularization is inhibited by the dithiocarbamate pesticide thiram in chickens: potential relationship to peripheral platelet counts alteration. Environ Sci Pollut Res Int 2019;26:36322-32. [PMID: 31713825 DOI: 10.1007/s11356-019-06664-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Yokoyama A, Yokoyama T, Mizukami T, Matsui T, Kimura M, Matsushita S, Higuchi S, Maruyama K. Platelet Counts and Genetic Polymorphisms of Alcohol Dehydrogenase-1B and Aldehyde Dehydrogenase-2 in Japanese Alcoholic Men. Alcohol Clin Exp Res 2017;41:171-8. [PMID: 27991683 DOI: 10.1111/acer.13283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Pang Q, Zhang JY, Xu XS, Song SD, Qu K, Chen W, Zhou YY, Miao RC, Liu SS, Dong YF, Liu C. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol 2015; 21(18): 5607-5621 [PMID: 25987786 DOI: 10.3748/wjg.v21.i18.5607] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
57 de Oliveira Rech B, Rocha Tenório J, Bertoldi Franco J, Medina JB, Gallottini M, Pérez-Sayáns M, Ortega KL. Risk of bleeding during oral surgery in patients with liver cirrhosis: A systematic review. J Am Dent Assoc 2021;152:46-54.e2. [PMID: 33250169 DOI: 10.1016/j.adaj.2020.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Leone G, Pizzigallo E. Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. Mediterr J Hematol Infect Dis 2015;7:e2015057. [PMID: 26543526 DOI: 10.4084/MJHID.2015.057] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
59 Saab S, Bernstein D, Hassanein T, Kugelmas M, Kwo P. Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure. J Clin Gastroenterol 2020;54:503-11. [PMID: 32195771 DOI: 10.1097/MCG.0000000000001338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ichimata S, Kobayashi M, Honda K, Shibata S, Matsumoto A, Kanno H. Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World J Gastroenterol 2017; 23(35): 6540-6545 [PMID: 29085203 DOI: 10.3748/wjg.v23.i35.6540] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
61 Peng W, Li C, Zhang X, Wen T, Chen Z. The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis. World J Surg Oncol 2021;19:46. [PMID: 33573630 DOI: 10.1186/s12957-021-02160-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Ameyaw EO, Koffuor GA, Asare KK, Konja D, Du-Bois A, Kyei S, Forkuo AD, Abankwah Owusu Mensah RN. Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complications. J Intercult Ethnopharmacol 2016;5:263-73. [PMID: 27366353 DOI: 10.5455/jice.20160606124435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
63 Katsube T, Shimizu R, Fukuhara T, Kano T, Wajima T. Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures. Clin Pharmacokinet 2019;58:1469-82. [PMID: 31055790 DOI: 10.1007/s40262-019-00770-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]